Xizang Weixinkang Pharmaceutical issued a notice of unusual movement. After the company's self-examination and verification with the actual controller, controlling shareholders, and their concerted actors, as of the date of this announcement, there are no significant matters that should be disclosed but have not been disclosed, except for information that has been publicly disclosed in designated media. This includes but is not limited to major asset restructuring, share issuance, significant transaction matters, business restructuring, share repurchase, equity incentives, bankruptcy reorganization, major business cooperation, and the introduction of strategic investors. The company's current operating status is normal, and there have been no significant changes in the internal and external operating environment